Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jingzan Wei"'
Autor:
Bowen Zhang, Jixue Xu, Junzhi Liang, Mingjun Hao, Yuexin Yu, Jingzan Wei, Yuanyuan Fang, Zhijing Na, Da Li
Publikováno v:
MedComm – Future Medicine, Vol 2, Iss 3, Pp n/a-n/a (2023)
Abstract Coronavirus disease 2019 (COVID‐19) has experienced a global pandemic, and currently, the emergence of its variants has posed challenges in terms of prevention and treatment. Nonetheless, the effect of COVID‐19 infection on female reprod
Externí odkaz:
https://doaj.org/article/5775bae27d764f8d97250279a21a0da3
Autor:
Jingzan Wei, Yanyan Zhao
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
Polycystic Ovary Syndrome (PCOS) is a heterogeneous endocrine disease with high incidences in women of reproductive age. Although miR-185-5p (miR-185) was decreased in PCOS patients, the exact function of miR-185 on PCOS development still requires fu
Externí odkaz:
https://doaj.org/article/d2a5afbf4ae540a3a60e9eabd151cab5
Publikováno v:
Journal of the American Medical Directors Association. 24:846-854
Autor:
Zhijing Na, Jiahui Song, Yaxin Meng, Di Feng, Jingzan Wei, Hongyu Jiang, Hongyue Yang, Yuanyuan Peng, Dongkai Cheng, Yuanyuan Fang, Da Li
Publikováno v:
Reproductive biomedicine online. 45(3)
Is there an association between fructose and dislipidaemia in polycystic ovary syndrome (PCOS)?Serum fructose levels were measured in 250 women with PCOS (113 with dislipidaemia, 137 with normolipidaemia) and 460 controls (70 with dislipidaemia, 390
Autor:
Yanyan Zhao, Jingzan Wei
Publikováno v:
Frontiers in Pharmacology
Frontiers in Pharmacology, Vol 11 (2020)
Frontiers in Pharmacology, Vol 11 (2020)
Polycystic Ovary Syndrome (PCOS) is a heterogeneous endocrine disease with high incidences in women of reproductive age. Although miR-185-5p (miR-185) was decreased in PCOS patients, the exact function of miR-185 on PCOS development still requires fu